510(k) device
Cochlear Osia 2 System
Cochlear Americas · Active Implantable Bone Conduction Hearing System (PFO, Class II) · First FDA decision Jul 27, 2022, newest Jul 27, 2022Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
7
Naming "Osia 2"
MAUDE reports
49
Brand "Osia 2", since 2015
PubMed studies
30
Mentioning "Osia 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cochlear Osia 2 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K220922 · Decided Jul 27, 2022 · 118 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Osia 2", any status and sponsor, newest update first.
CochlearNot on our public-company list
NCT07130136 · 20 participants (planned) · Start Jul 24, 2026 · Primary completion Nov 2028
Device: Cochlear™ Osia® System; Cochlear™ Baha® System · For: Bone Conduction; Hearing Loss, Conductive; Hearing Loss, Mixed
Sites: London, United Kingdom; Nottingham, United Kingdom; Sheffield, United Kingdom
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Osia 2", and for the whole product code for context.
This brand
49 reports: 3 malfunction, 46 injury, 0 death
Whole product code PFO
3,616 reports: 378 malfunction, 3,236 injury, 1 death
Newest reports for this brand
6000034-2026-02530 · Received Jul 14, 2026
Device type: Active Implantable Bone Conduction Hearing System (PFO)
Device problem as coded: Inadequacy of Device Shape and/or Size
Patient problem as coded: Purulent Discharge; Unspecified Infection; Skin Inflammation/ Irritation
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Osia 2"[tiab]. The summary above synthesizes these.
- How I do it: Cochlear Osia 2 System surgery placement.
Soloperto D, Dallari V, Molteni G · Eur Arch Otorhinolaryngol · 2023
- Hearing Rehabilitation with Osia®2 in Patients with Bonebridge® Failure.
Yun JM, Nam Y, Lapina G, et al. · Yonsei Med J · 2025
- Early Osia® 2 bone conduction hearing implant experience: Nationwide controlled-market release data and single-center outcomes.
Goldstein MR, Bourn S, Jacob A · Am J Otolaryngol · 2021
- Artefacts on magnetic resonance imaging with Osia®2 bone conduction hearing aid: A cadaver study.
Diosi B, Bere Z, Csomor A, et al. · Cochlear Implants Int · 2024Research Support, Non-U.S. Gov't
- Outcomes Following Cochlear Osia 2 Implantation in Patients Ages 5-11ߙYears: A Multi-Center Trial.
Stevens SM, Meyer A, Rivas A, et al. · Laryngoscope · 2025Multicenter Study, Clinical Trial
- The impact of the Cochlearࡊ Osia® 2 System on patients with mixed or conductive hearing loss: A comparison with Cochlearࡊ Baha® Attract System outcomes.
Park KS, Kim HC, Lee S, et al. · Sci Prog · 2024Comparative Study, Research Support, Non-U.S. Gov't
- Innovative surgical approaches for the Osia® 2 System.
Lee JW, Lee HS, Seo YJ · Acta Otolaryngol · 2025
- Modifications to Implanting the OSIA® 2 Bone Conduction Hearing Implant: How I Do it.
Deep NL, Johnson BJ, Kay-Rivest E, et al. · Laryngoscope · 2022
- Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study.
Jukic A, Cismas M, Flores N, et al. · Otolaryngol Head Neck Surg · 2024
- How I do it: implantation of Osia® 2 system under local anesthesia.
Posta B, Rovó L, Bere Z · Eur Arch Otorhinolaryngol · 2024Case Reports
- Minimally invasive subperiosteal pocket technique for Osia 2 system- implantation without fixation.
Bere Z, Nagy R, Posta B, et al. · Eur Arch Otorhinolaryngol · 2025
- Piezoelectric Bone Conduction Hearing Implant: A Case Series of Audiological, Surgical and Patient-Reported Outcomes.
Vagle M, Bille M, Gordon Jensen R · J Clin Med · 2024
Other devices of this type
Also filed under product code PFO.
- BONEBRIDGE System, SAMBA 2 BB, SYMFIT 8.0, SAMBA 2 GO, SAMBA 2 RemoteMed-El Elektromedizinische Geraete GmbH · De Novo 2020
- Cochlear Osia® 3(I) Sound ProcessorCochlear Americas · 510(k) 2026
- Sentio Ti Implant KitOticon Medical AB · 510(k) 2024
- Cochlear Osia SystemCochlear Americas · 510(k) 2024
- Cochlear Osia® SystemCochlear · 510(k) 2023
- BCI 602 Lifts (1 mm)Med-El Elektromedizinische Geraete GmbH · 510(k) 2020
- Cochlear Osia OSI200 ImplantCochlear Americas · 510(k) 2019
- Cochlear Osia OSI100 ImplantCochlear Americas · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.